Connect with us

Stocks

Moderna to Ship 100-125 Million Doses of COVID-19 Vaccine in Q1/2021

Moderna Inc. expects to have between 100 million and 125 million doses of the company’s Covid-19 vaccine available globally in the first quarter of 2021.

Published

on

This article was originally published by PharmaLive.

Moderna to supply 100 to 125 million COVID-19 vaccine doses globally in first quarter

(Reuters) – Moderna Inc said on Thursday it expects to have between 100 million and 125 million doses of its COVID-19 vaccine available globally in the first quarter of 2021.

The company said 85 million to 100 million of those doses would be available in the United States, with 15 million to 25 million outside the country.

The first-quarter doses are within the 500 million to up to 1 billion doses the company expects to manufacture globally in 2021, Moderna said.

Results from an early-stage trial showed that the vaccine, mRNA-1273, produced high levels of binding and neutralizing antibodies that declined slightly over time, but remained elevated in all participants three months after the booster vaccination, the company said.

The drugmaker’s shares were down about 2% at $154.4 after the bell.

FILE PHOTO: A small shopping basket filled with vials labeled “COVID-19 – Coronavirus Vaccine” and a medical sryinge are placed on a Moderna logo in this illustration taken November 29, 2020. Picture taken November 29, 2020. REUTERS/Dado Ruvic/Ilustration

 

Reporting by Dania Nadeem in Bengaluru; Editing by Devika Syamnath

 

Reuters source:

https://www.reuters.com/article/us-health-coronavirus-moderna/moderna-to-supply-up-to-125-million-covid-19-vaccine-doses-globally-in-first-quarter-idUSKBN28D3FA

 

Read More

Continue Reading
Advertisement